CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,438 | -22.3% | 71,776 | 0.0% | 0.00% | – |
| Q2 2023 | $80,389 | -49.0% | 71,776 | -52.7% | 0.00% | -100.0% |
| Q1 2023 | $157,704 | +83785.1% | 151,638 | -9.5% | 0.00% | 0.0% |
| Q4 2022 | $188 | -100.0% | 167,582 | -59.2% | 0.00% | -50.0% |
| Q3 2022 | $464,000 | -58.3% | 410,691 | -45.7% | 0.00% | -50.0% |
| Q2 2022 | $1,112,000 | -46.9% | 756,200 | -17.2% | 0.00% | -33.3% |
| Q1 2022 | $2,093,000 | -53.4% | 913,789 | -44.1% | 0.01% | -53.8% |
| Q4 2021 | $4,495,000 | +3877.9% | 1,634,412 | +8559.6% | 0.01% | – |
| Q3 2021 | $113,000 | -62.3% | 18,874 | -84.4% | 0.00% | -100.0% |
| Q1 2021 | $300,000 | – | 121,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |